Nasal nitric oxide measurement in allergic rhinitis and non-allergic rhinitis: a meta-analysis

The goal of this meta -analysis was to study nasal nitric oxide (nNO) measurements in allergic rhinitis (AR) and non -allergic rhinitis (non -AR). The protocol was registered with PROSPERO (no: CRD4202124828). Electronic databases from PubMed, Google Scholar, Scopus, Web of Science, and Cochrane were all thoroughly searched and studies were chosen based on the qualifying requirements. The quality of the studies was evaluated by Joanna Briggs Institute evaluation tools, and publication bias using funnel plots. The metaanalysis included 18 studies, whereas the systematic review included 20 studies, totaling 3097 participants (1581 AR, 458 non -AR, and 1058 healthy/control). Patients with AR had significantly greater nNO levels than the control group, although this did not change significantly before or after treatment. AR patients had significantly greater nNO levels than non -AR patients, but there was no significant difference between non -AR patients and healthy controls. Nineteen of the studies were of high quality and the remaining one was of moderate quality. nNO measurement has a promising role in the management of AR and non -AR patients, but more investigations are needed to document clinical benefits.